All lobbying filings

PROFESSIONAL COMPOUNDING CENTERS OF AMERICA

Lobbying for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Texas · House · Senate · $140,000.00 expenses · posted Oct 20, 2025

Official filing document

Bills named in this filing 1

HR 5316
Drug Shortage Compounding Patient Access Act of 2025

Lobbying activity 3

Medicare/Medicaid

Issues related to Medicare coverage of compounded medications, Drug shortages and Medicare reimbursement for compounded medications, pharmacy direct and indirect remuneration fees

Budget/Appropriations

Agriculture appropriations spending bill; Department of Labor-Health and Human Services appropriations bill

Pharmacy

Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages; H.R. 5316, the Drug Shortage Compounding Patient Access Act of 2025

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.